Publications and Digital Products

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.

This flyer is related to the public service announcement from SAMHSA’s “Talk. They Hear You.” campaign for military parents to talk with their kids about marijuana.

This wallet card is related to the public service announcement from SAMHSA’s “Talk. They Hear You.” campaign encouraging parents to talk with their kids about marijuana.

This flyer is related to the public service announcement from SAMHSA’s “Talk. They Hear You.” campaign encouraging parents to talk with their kids about marijuana.

This flyer is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about opioids.

This wallet card is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging military parents to talk with their kids about opioids.

This wallet card is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about opioids.

This wallet card is related to the public service announcement from SAMHSA’s “Talk. They Hear You.” campaign for military parents to talk with their kids about marijuana.

This fact sheet about the public service announcement from SAMHSA's “Talk. They Hear You.” campaign for parents on why they should talk with their kids about alcohol and substance use.